Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
475 participants
OBSERVATIONAL
2019-01-19
2028-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We anticipate our work will provide insights of use to clinicians and patients with hypersensitivity pneumonitis and other interstitial lung diseases.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
NCT00470327
Research for Specific Proteins of Interest for the Serological Diagnosis of Bird Fancier's Lung
NCT03056404
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
NCT00608764
Race, Ethnicity, and Diffuse Parenchymal Lung Disease
NCT00453713
The Genetics of Pulmonary Fibrosis
NCT03478553
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Consenting subjects will complete questionnaires, provide blood samples for genetic analysis and immunological testing and undertake lung function measurements.
Subjects will be observed, and encouraged to report referral to specialist respiratory services, and following this information will be sought on diagnosis (including supporting evidence). Where interstitial lung disease is detected this will be linked to subsequent unbiased analysis to detect potential predisposing genetic associations.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Genetic profiling
All participating subjects will undergo detailed genetic analysis, with the aim of detecting novel genetic drivers for the development of interstitial lung disease in the context of known sensitising agent (pigeon antigen)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Leicester
OTHER
University of Glasgow
OTHER
Newcastle University
OTHER
British Lung Foundation
OTHER
British Pigeon Fanciers Medical Research
UNKNOWN
University of Dundee
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mark Spears
Dr Mark Spears, Consultant in Respiratory Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Spears, PhD, FRCP
Role: PRINCIPAL_INVESTIGATOR
NHS Tayside & University of Dundee
Louise Wain, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Leicester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Scottish Homing Union
Lanark, Lanark, United Kingdom
Royal Pigeon Racing Association Meeting
Blackpool, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MS001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.